On April 1, 2020, the U.S. Food and Drug Administration (FDA) requested the immediate withdrawal of all Zantac (ranitidine) products from the market. The agency took this action after independent studies revealed that the products could contain N-nitrosodimethylamine (NDMA), a probable human carcinogen and that…
A Delaware health insurance company recently filed a new metformin class-action lawsuit against manufacturer Aurobindo Pharma and others to recover payments made for the defendants’ “contaminated and adulterated metformin drugs.” The plaintiff seeks to represent other similarly situated healthcare insurers who had to pay the…
After online pharmacy Valisure found toxic chemical N-nitrosodimethylamine (NDMA) in samples of Zantac (ranitidine), it sent a citizen’s petition to the U.S. Food and Drug Administration (FDA) requesting a recall of all forms of the acid-reducing drug. The FDA conducted its own tests, found similar…
A Virginia woman recently filed a new Zantac lawsuit in the U.S. District Court for the District of New Jersey. The woman claims that after taking the drug for several years, she suffered serious injuries, and she seeks to hold the defendants liable for damages,…
When online pharmacy Valisure first found cancer-causing N-nitrosodimethylamine (NDMA) in Zantac, it informed the Food and Drug Administration (FDA) that the carcinogen was not an impurity, but rather, a result of an unstable ranitidine molecule. The company noted that because of this, every type or…
A California man recently filed a new Zantac lawsuit in the U.S. District Court for the Southern District of California. He claims that after taking the acid-reducing drug for about eight years, he suffered serious injuries. He seeks both compensatory and punitive damages. Plaintiff Takes…
An Ohio woman recently filed a new Zantac lawsuit in the U.S. District Court for the Northern District of Ohio. She says that after years of taking the product, she developed kidney cancer. This is one of many lawsuits that are expected to be filed…
On November 19, 2019, a North Carolina woman filed a new Zantac lawsuit in the U.S. District Court for the Western District of North Carolina. She claims that after taking Zantac for years, she was diagnosed with stomach cancer, which she blames on the acid-reducing…
As more companies recall Zantac and generic ranitidine products because of concerns they may contain the carcinogen N-Nitrosodimethylamine (NDMA), a new report indicates that other drugs may also be affected, creating a potentially more widespread problem. The FDA started investigating NDMA impurities in blood pressure…
The gout medication Uloric (febuxostat) may increase the risk of heart attack, according to recent studies. The FDA recently required manufacturer Takeda Pharmaceuticals place a new black-box warning on the product label to alert doctors and patients to an increased risk of heart-related death and…
